
GLP-1 uptake boosts Hershey's mint and gum sales
Hershey CEO Kirk Tanner said Ice Breakers mints and gum benefited from the growing adoption of GLP-1 drugs, with Ice Breakers sales rising over 8% in Q1 and overall quarterly revenue up more than 10%. While some GLP-1 users report halitosis, Ozempic breath is not an official side effect and dry mouth is a noted issue; the trend mirrors boosts in premium snacks at Lindt and Magnum as GLP-1 adoption reshapes snacking.












